Monday, 3 October 2016

Samsung Affiliate Seeks European Approval for Herceptin Copy


Samsung Group’s biologic drug-development affiliate submitted a near-replica of blockbuster breast cancer drug Herceptin for regulatory approval in Europe.
http://on.wsj.com/2dncv9K
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)